0       0

AMDA's 2015 Annual Conference


B30a - General Session I - How Are We Going to Live with Alzheimer's Disease? - CME/CMD credits not available for this session


Mar 20, 2015 8:00am ‐ Mar 20, 2015 10:30am


Credits: None available.

Standard: $24.00

Description

Accreditation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine designates this Internet Enduring Material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABPLM Designation Statement: This Internet Enduring Material has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 2 clinical hours toward certification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM.  Each physician should claim only those hours of credit actually spent on the activity.

Session Description:
Alzheimer’s disease confronts us with an ethical challenge: How do we live with dignity and quality of life in the face of progressive disability and, ultimately, death? Patients’ cognitive and decision-making impairments often make them unable to answer this question, and when professionals who provide care and services for older adults fail to recognize and accommodate these impairments, patients suffer. Patients and their caregivers need a health care system that fosters caregiving so that each will live with dignity and well-being. Why don’t we have such a system, and what do we need to do to achieve it? The answers to these questions engage a fascinating collection of historical and cultural events, ethical issues, and promising but challenging ideas and initiatives.

Jason Karlawish, MD is a Professor of Medicine, Medical Ethics and Health Policy at the University of Pennsylvania. He is the Director of Penn’s Neurodegenerative Disease Ethics and Policy Program and Associate Director of the Penn Memory Center. His clinical practice focuses on the diagnosis and treatment of persons with Alzheimer’s disease and related disorders. His research focuses on ethical, legal and social issues in research and care of older adults, and persons with late-life cognitive disorders such as Alzheimer’s disease and Parkinson’s disease. His has investigated issues in dementia drug development, informed consent, quality of life, research and treatment decision making, biomarkers, and voting by persons with cognitive impairment and residents of long-term care facilities.

Learning Objective(s):

  • Describe how Alzheimer’s disease impacts on the quality of lives of patients and their family members
  • Discuss the historical and cultural events that have shaped the ways we do and do not care for patients with Alzheimer’s disease
  • Recognize how advances in the assessment of decision making capacity can improve conversations with patients and their family members
  • Identify changes in healthcare that promise to help us live with Alzheimer’s disease

Speaker(s):
Jason Karlawish, MD

Disclosure(s):
None

Reference(s):
None

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content